Clinical trial
Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil
NCT00265278 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- March 31, 2005
- Completion date
- March 31, 2006
- Enrollment
- 16
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.